Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
The Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market is projected to grow significantly, reaching an estimated US$ 918.9 million by 2031, up from US$ 389.6 million in 2024. This growth represents a compound annual growth rate (CAGR) of 13.2% from 2025 to 2031, driven by rising diabetes prevalence, technological advancements, and supportive healthcare policies across the region.
The market is primarily segmented into key countries: the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia stands out as a leader in this market, with a diabetes prevalence rate of 23.1% among adults, translating to over 5.3 million cases expected in 2024, according to the International Diabetes Federation (IDF). The Saudi government is actively enhancing healthcare services, particularly through the integration of digital health solutions, which has accelerated the adoption of CGM devices. Similarly, the UAE has improved access to CGM systems like Dexcom G7 and FreeStyle Libre, available through pharmacies and specialized clinics, facilitating better diabetes management.
In South Africa, the increasing incidence of type 2 diabetes, largely attributed to unhealthy diets and sedentary lifestyles, has spurred demand for CGM technologies. Approximately 4.2 million South Africans are living with diabetes, leading to a heightened interest in CGM devices for real-time glucose management. The COVID-19 pandemic has further catalyzed the adoption of CGM devices, emphasizing the importance of remote patient monitoring and overcoming regulatory hurdles. This shift has increased the demand for CGM technologies, particularly in home care settings, where patients prefer convenient and self-managed diabetes care.
Key players in the market, such as Dexcom and Medtronic, are expanding their presence in the region. Dexcom has made its CGM systems available through various healthcare providers and pharmacies in countries like Qatar and Egypt, where diabetes management is a public health priority. Medtronic is also forming partnerships with local healthcare systems to enhance access to its CGM technologies, focusing on countries like South Africa and Kenya, where there is a growing need for advanced diabetes care solutions.
The CGMD market is segmented by product, application, testing sites, and end users. In terms of product, the market includes sensors, transmitters, and receivers, with sensors holding the largest market share in 2024. By application, the market is divided into Type 1 and Type 2 diabetes, with Type 2 diabetes dominating the market. Testing sites are categorized into fingertip testing and alternate site testing, with fingertip testing leading in market share. Finally, the end-user segment includes hospitals and clinics, as well as self or home care, with self-care being the largest segment in 2024.
The global rise in diabetes prevalence is a significant driver for the CGM market. Recent statistics indicate that the proportion of adults with diabetes has doubled over the past three decades, increasing from approximately 7% in 1990 to 14% by 2022, affecting over 800 million people worldwide. Projections suggest that this number could rise to 853 million by 2050, marking a 46% increase. The rise is particularly pronounced in low- and middle-income countries (LMICs), where about 59% of diabetic adults remain untreated, highlighting disparities in access to diagnosis and management tools.
The increasing prevalence of type 2 diabetes, driven by lifestyle changes and demographic shifts, is a key factor in this epidemic. Urbanization, aging populations, sedentary lifestyles, and rising obesity rates are contributing to the growth of diabetes, particularly in regions like Africa, where a 142% increase in diabetes cases is expected by 2050. This situation underscores the urgent need for effective diabetes management solutions, such as CGMs, which provide real-time insights and enable better glycemic control, crucial for preventing complications like cardiovascular disease and kidney failure.
Despite the alarming statistics, a significant portion of the diabetic population remains undiagnosed, indicating a substantial unmet clinical need for CGMs as part of a comprehensive diagnostic and monitoring strategy. The relentless rise in diabetes prevalence, influenced by modifiable lifestyle factors and socio-economic disparities, creates a favorable environment for CGM adoption. Healthcare systems, clinicians, and patients are increasingly prioritizing tools that facilitate continuous monitoring and improved compliance, leading to better long-term health outcomes.
In summary, the Middle East & Africa Continuous Glucose Monitoring Device market is poised for substantial growth, driven by the increasing prevalence of diabetes, advancements in technology, and supportive healthcare initiatives. As the demand for effective diabetes management solutions continues to rise, CGM devices are becoming essential tools in addressing the growing health burden of diabetes in the region.
The market is primarily segmented into key countries: the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia stands out as a leader in this market, with a diabetes prevalence rate of 23.1% among adults, translating to over 5.3 million cases expected in 2024, according to the International Diabetes Federation (IDF). The Saudi government is actively enhancing healthcare services, particularly through the integration of digital health solutions, which has accelerated the adoption of CGM devices. Similarly, the UAE has improved access to CGM systems like Dexcom G7 and FreeStyle Libre, available through pharmacies and specialized clinics, facilitating better diabetes management.
In South Africa, the increasing incidence of type 2 diabetes, largely attributed to unhealthy diets and sedentary lifestyles, has spurred demand for CGM technologies. Approximately 4.2 million South Africans are living with diabetes, leading to a heightened interest in CGM devices for real-time glucose management. The COVID-19 pandemic has further catalyzed the adoption of CGM devices, emphasizing the importance of remote patient monitoring and overcoming regulatory hurdles. This shift has increased the demand for CGM technologies, particularly in home care settings, where patients prefer convenient and self-managed diabetes care.
Key players in the market, such as Dexcom and Medtronic, are expanding their presence in the region. Dexcom has made its CGM systems available through various healthcare providers and pharmacies in countries like Qatar and Egypt, where diabetes management is a public health priority. Medtronic is also forming partnerships with local healthcare systems to enhance access to its CGM technologies, focusing on countries like South Africa and Kenya, where there is a growing need for advanced diabetes care solutions.
The CGMD market is segmented by product, application, testing sites, and end users. In terms of product, the market includes sensors, transmitters, and receivers, with sensors holding the largest market share in 2024. By application, the market is divided into Type 1 and Type 2 diabetes, with Type 2 diabetes dominating the market. Testing sites are categorized into fingertip testing and alternate site testing, with fingertip testing leading in market share. Finally, the end-user segment includes hospitals and clinics, as well as self or home care, with self-care being the largest segment in 2024.
The global rise in diabetes prevalence is a significant driver for the CGM market. Recent statistics indicate that the proportion of adults with diabetes has doubled over the past three decades, increasing from approximately 7% in 1990 to 14% by 2022, affecting over 800 million people worldwide. Projections suggest that this number could rise to 853 million by 2050, marking a 46% increase. The rise is particularly pronounced in low- and middle-income countries (LMICs), where about 59% of diabetic adults remain untreated, highlighting disparities in access to diagnosis and management tools.
The increasing prevalence of type 2 diabetes, driven by lifestyle changes and demographic shifts, is a key factor in this epidemic. Urbanization, aging populations, sedentary lifestyles, and rising obesity rates are contributing to the growth of diabetes, particularly in regions like Africa, where a 142% increase in diabetes cases is expected by 2050. This situation underscores the urgent need for effective diabetes management solutions, such as CGMs, which provide real-time insights and enable better glycemic control, crucial for preventing complications like cardiovascular disease and kidney failure.
Despite the alarming statistics, a significant portion of the diabetic population remains undiagnosed, indicating a substantial unmet clinical need for CGMs as part of a comprehensive diagnostic and monitoring strategy. The relentless rise in diabetes prevalence, influenced by modifiable lifestyle factors and socio-economic disparities, creates a favorable environment for CGM adoption. Healthcare systems, clinicians, and patients are increasingly prioritizing tools that facilitate continuous monitoring and improved compliance, leading to better long-term health outcomes.
In summary, the Middle East & Africa Continuous Glucose Monitoring Device market is poised for substantial growth, driven by the increasing prevalence of diabetes, advancements in technology, and supportive healthcare initiatives. As the demand for effective diabetes management solutions continues to rise, CGM devices are becoming essential tools in addressing the growing health burden of diabetes in the region.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
5.2 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Forecast and Analysis
6. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY PRODUCT
6.1 Sensors
6.1.1 Overview
6.1.2 Sensors: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Transmitters
6.2.1 Overview
6.2.2 Transmitters: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Receivers
6.3.1 Overview
6.3.2 Receivers: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Type 1 Diabetes
7.1.1 Overview
7.1.2 Type 1 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Type 2 Diabetes
7.2.1 Overview
7.2.2 Type 2 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY TESTING SITES
8.1 Fingertip Testing
8.1.1 Overview
8.1.2 Fingertip Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Alternate Site Testing
8.2.1 Overview
8.2.2 Alternate Site Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Self or Homecare
9.2.1 Overview
9.2.2 Self or Homecare: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.1.2.2.2 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.1.2.2.4 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.2.3.3.2 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.2.3.3.4 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.3.4.4.2 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.3.4.4.4 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Tandem Diabetes Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed Holding AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dexcom Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 i-SENS Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Senseonics Holdings Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 A. Menarini Diagnostics s.r.l
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Medtrum Technologies Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
5.2 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Forecast and Analysis
6. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY PRODUCT
6.1 Sensors
6.1.1 Overview
6.1.2 Sensors: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Transmitters
6.2.1 Overview
6.2.2 Transmitters: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Receivers
6.3.1 Overview
6.3.2 Receivers: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Type 1 Diabetes
7.1.1 Overview
7.1.2 Type 1 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Type 2 Diabetes
7.2.1 Overview
7.2.2 Type 2 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY TESTING SITES
8.1 Fingertip Testing
8.1.1 Overview
8.1.2 Fingertip Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Alternate Site Testing
8.2.1 Overview
8.2.2 Alternate Site Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Self or Homecare
9.2.1 Overview
9.2.2 Self or Homecare: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING DEVICE (CGMD) MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.1.2.2.2 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.1.2.2.4 Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.2.3.3.2 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.2.3.3.4 South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.3.4.4.2 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.3.4.4.4 United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Product
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by Testing Sites
10.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Tandem Diabetes Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed Holding AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Dexcom Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 i-SENS Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Senseonics Holdings Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 A. Menarini Diagnostics s.r.l
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Medtrum Technologies Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Segmentation
Table 3. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 7. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 10. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 12. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 16. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 20. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 23. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 24. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
Table 1. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Segmentation
Table 3. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 7. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 10. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 12. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 16. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 20. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 23. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Testing Sites
Table 24. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Segmentation - Country
Figure 4. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product, 2024 and 2031
Figure 8. Sensors: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Transmitters: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Receivers: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application, 2024 and 2031
Figure 12. Type 1 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Type 2 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites, 2024 and 2031
Figure 15. Fingertip Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Alternate Site Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User, 2024 and 2031
Figure 18. Hospitals and Clinics: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Self or Homecare: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 21. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
Figure 1. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Segmentation - Country
Figure 4. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product, 2024 and 2031
Figure 8. Sensors: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Transmitters: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Receivers: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application, 2024 and 2031
Figure 12. Type 1 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Type 2 Diabetes: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites, 2024 and 2031
Figure 15. Fingertip Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Alternate Site Testing: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User, 2024 and 2031
Figure 18. Hospitals and Clinics: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Self or Homecare: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 21. Saudi Arabia: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. South Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. United Arab Emirates: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of Middle East & Africa: Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
